Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience. [electronic resource]
Producer: 20121108Description: 835-40 p. digitalISSN:- 1791-2431
- Aged
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Antineoplastic Agents -- adverse effects
- Disease-Free Survival
- Female
- Hepacivirus
- Hepatitis C -- complications
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse -- complications
- Male
- Middle Aged
- Retrospective Studies
- Rituximab
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.